FONAR Corporation EPS Ratio 2011-2026 | FONR

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio FONAR Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.78	1.47	1.28	2.41	-	-	2.6	2.13	1.73	1.46	1	0.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.6	0.6	1.65

Quarterly EPS Ratio FONAR Corporation

2025-Q4	2025-Q3	2025-Q1	2024-Q4	2024-Q3	2024-Q1	2023-Q4	2023-Q3	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
0.3	0.33	0.37	0.28	0.5	0.27	0.58	0.64	0.6	0.34	0.31	0.62	0.33	0.58	0.56	1.13	0.55	0.45	0.39	0.48	0.39	0.48	0.51	0.48	0.51	0.56	0.52	0.56	0.55	0.67	0.59	0.67	0.96	0.69	0.58	0.69	0.58	0.58	0.47	0.58	0.47	0.44	0.42	0.44	0.42	0.33	0.38	0.33	0.38	0.21	0.23	0.21	0.23	0.25	0.25	0.25	0.25

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.13	0.21	0.469

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
Delcath Systems DCTH	0.08	$ 9.19	2.28 %	$ 329 M	USA
BioSig Technologies BSGM	-0.75	-	37.08 %	$ 85.7 M	USA
Axonics Modulation Technologies AXNX	-1.28	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	1.29	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	-2.81	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	-0.48	-	3.58 %	$ 2.21 M	USA
Second Sight Medical Products EYES	-0.43	-	-0.97 %	$ 54.4 M	USA
Conformis CFMS	-6.99	-	-	$ 16.4 M	USA
Helius Medical Technologies HSDT	-14.6	$ 2.14	6.47 %	$ 1.3 M	USA
Integra LifeSciences Holdings Corporation IART	-0.09	$ 9.54	-	$ 735 M	USA
Inogen INGN	-0.86	$ 6.41	1.42 %	$ 171 M	USA
Cardiovascular Systems CSII	-0.94	-	0.15 %	$ 844 M	USA
IRIDEX Corporation IRIX	-0.59	$ 1.33	-1.48 %	$ 21.5 M	USA
IRadimed Corporation IRMD	1.77	$ 101.59	0.62 %	$ 1.29 B	USA
Apollo Endosurgery APEN	-0.98	-	-	$ 475 M	USA
Avinger AVGR	-23.3	-	-20.74 %	$ 369 K	USA
LivaNova PLC LIVN	-4.45	$ 63.64	1.99 %	$ 3.47 B	Britain
LENSAR LNSR	-2.73	$ 5.56	-	$ 64 M	USA
CONMED Corporation CNMD	1.52	$ 37.07	1.38 %	$ 1.15 B	USA
NanoVibronix NAOV	-13.7	-	-	$ 1.08 M	USA
Electromed ELMD	0.89	$ 24.71	0.02 %	$ 209 M	USA
Medtronic PLC MDT	3.63	$ 87.73	1.33 %	$ 113 B	USA
MiMedx Group MDXG	0.33	$ 4.11	-0.61 %	$ 607 M	USA
Cytosorbents Corporation CTSO	-0.38	$ 0.67	-4.18 %	$ 36.5 M	USA
Aethlon Medical AEMD	-8.58	$ 2.38	10.12 %	$ 3.71 M	USA
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA
Orthofix Medical OFIX	-2.33	$ 11.86	1.19 %	$ 470 M	Curacao
InspireMD NSPR	-0.76	$ 1.76	-1.68 %	$ 113 M	Israel
AdaptHealth Corp. AHCO	-0.52	$ 11.37	-1.0 %	$ 1.54 B	USA
Penumbra PEN	4.57	$ 336.27	0.63 %	$ 13.1 B	USA
Myomo MYO	-0.37	$ 0.69	-0.83 %	$ 28.9 M	USA
Insulet Corporation PODD	3.51	$ 217.14	-3.71 %	$ 15.3 B	USA
Nano-X Imaging Ltd. NNOX	-0.91	$ 2.3	-4.38 %	$ 135 M	Israel
Invacare Corporation IVC	-0.54	-	-	$ 24.7 M	USA
EDAP TMS S.A. EDAP	-0.51	$ 3.72	-4.86 %	$ 139 M	France
Profound Medical Corp. PROF	1.5	$ 5.9	14.47 %	$ 180 M	Canada
OrthoPediatrics Corp. KIDS	-1.69	$ 16.33	2.64 %	$ 383 M	USA
Quanterix Corporation QTRX	-2.51	$ 3.9	2.09 %	$ 166 M	USA
Outset Medical OM	-5.37	$ 3.49	-1.13 %	$ 53.1 K	USA